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 ABSTRACT 
PURPOSE. To evaluate the impact of self-acting eyetracking and retest software on 
the reproducibility of retinal nerve fiber layer (RNFL) thickness measurements in 
glaucoma patients and healthy control subjects using Spectralis® SD-OCT. 
 
METHODS.RNFL thickness was measured in 56 normal and 47 glaucomatous eyes 
by one operator within one session with a brief rest between measurements. Three 
measurements were taken with eyetracker and retest function engaged (Method A), 
and three measurements were taken without eye tracker and without retest function 
(Method B). Measurements with Method A and Method B were taken alternately. 
 
RESULTS. Reliability, measured by intraclass correlation coefficient (ICC) for 
absolute agreement and coefficient of variation (COV), was calculated for the 
globalmean RNFL thickness (G), for each sector and for the peripapillaryboundle. 
The ICC (and lower 95% confidence interval (CI)) for the global mean RNFL 
thickness(G) for measurements using Method A in both normal and glaucomatous 
eyes was 0.99 (0.98 CI). In glaucomatous eyes the COV for measurements using 
Method B was between 2.7% and 10.5%, and between 1.3% and 3.5% 
formeasurements usingMethod A. 
 
CONCLUSION. Reproducibility of RNFL measurements with Spectralis® SD-OCT is 
excellent in bothnormal and glaucomatous eyes and can be significantly improved by 
using its eye trackerand retest software. The gain of reproducibility by using the 
software is significantly higher in glaucomatous eyes than in normal eyes. These 
findings suggest that software applications are capable ofsignificantly improving 
reproducibility of RNFL thickness measurements. 
 INTRODUCTION 
Glaucoma is a widespread ophthalmicdisease leading to progressive loss of visual 
field function. The deathof retinal ganglion cells culminates in the loss of visual acuity 
making glaucoma one of the main causes of irreversible blindness in industrialized 
nations and worldwide.1, 2 Elevated intraocular pressure (IOP) is a major risk factor 
for the onset of glaucoma.3, 4 In addition to IOP, other risk factors are well known, 
such as age, family history and race.5 Primary open angle glaucoma (POAG) and 
Primary angle closure glaucoma (PACG) are the main forms of glaucoma in the 
world. Pseudoexfoliationglaucoma(PEX) is the main cause of secondary open angle 
glaucoma. 
 
By the time the lossof retinal ganglion cells is clinically detected, extended and 
irreversible damage has already occurred.6, 7Since effective therapy can protract the 
progress of glaucoma, early diagnosis is one of the main goals in the treatment of 
this disease. It is strongly believed that the thinning of the retinal nerve fiber layer 
(RNFL) correlates highly to,or even precedes visual field loss in glaucoma.8-14 
Therefore, establishing reliable methods of RNFL measurement could be one key 
step in early diagnosis and treatment of glaucoma. 
 
Using optical coherence tomography (OCT), Huang et al. were the first to present a 
non-contact, non-invasive method of using low-coherence interferometry to 
determine the echo time delay and magnitude of backscattered light reflected off 
different layers of a structured tissue sample.15 The unique optic free pathway 
through the eye made OCT highly applicable to the visualization of retina layers. In 
1995, time domain OCT (TD-OCT) was introduced as an imaging technique for 
glaucoma diagnosis.13 In spectral domain OCT (SD-OCT or Fourier domain OCT), a 
 moving reference mirror as used in TD-OCT is no longer needed.16, 17 SD-OCT 
provides higher resolution at faster scanning speeds.18 
 
Another invention available in recent OCT devices is the implementation of specific 
algorithms and software to further enhance scanning resolution and decrease motion 
artifacts. In 2006, Spectralis® SD-OCT (Heidelberg Engineering GmbH, Heidelberg, 
Germany) was introduced for retinal imaging. This instrument features two different 
options to enhance reproducibility. An online eye tracking device (eye tracker) 
compensates for involuntary eye movements during the scanning process, and a 
retest function assures that follow-up measurements are taken from the same area of 
the retina as the baseline examination. Both options can be switched off. The aim of 
this study was to test the impact of using both the eye tracker and retest functions on 
the reproducibility of RNFL thickness measurements performed with Spectralis® SD-
OCT. 
 
METHODS  
Subjects 
The study was conducted in accordance withthe guidelines of the Declaration of 
Helsinki and was approved by the local ethics committee. Written informed consent 
was obtained from each subject. Subjects were recruited from the ophthalmological 
out-patient service of the UniversityHospital Zurich, Switzerland. All subjects 
underwent a full ophthalmological examination including measurement of refraction, 
best corrected visual acuity, intraocular pressure (Goldman applanation tonometry) 
and a slit lamp examination of the anterior and posterior segment. 
 
 The inclusion criteria for both healthy and glaucomatous subjects were a visual acuity 
of more or equal to 0.5 Snellen, refractive error less than ±5.00 diopters (D) spheric 
and ±3.00 D cylindrical and no history of ocular trauma or of any other severe ocular 
disease (particularly diseases affecting the optic nerve or surgery other than 
uncomplicated cataract surgery). Additional inclusion criteria for the glaucoma group 
were a diagnosis of primary open angle glaucoma (POAG) or PEX-glaucoma. All 
glaucoma patients underwent visual field (VF) testing. Young patients in the control 
group with normal optic disc and no or nearly no cupping were included into the 
studywithout VF testing. If IOP or the cupping was abnormal or even if there was a 
difference in sides, VF was tested in control patients.Regarding the VF tested with 
G1-program by Octopus perimeter (Haag-Streit AG, Koeniz, Switzerland),the mean 
defect (MD) for control patientshad to be less than or equal to 2.0dB and greater than 
2.0dB for glaucoma patients. Exclusion criteria for the control group were history of 
glaucoma or intraocular pressure beyond 21 mmHg and optic disc cupping of more 
than 0.6. Age was not an exclusion criterion. 
In general,glaucoma was defined based on a clinical diagnosis of a progressive optic 
nerve damage with abnormal optic disc cupping and MD >2.0dB. We assessed the 
optic disc in accordance withthe paper of Jonas et al.19Primary open-angle glaucoma 
is characterized as anoptic nerve neuropathy with atrophy of the optic nerve and loss 
of retinal ganglion cells and axons and in combination with characteristic visual field 
abnormalities. The anterior chamber angle is open.20PEX-glaucoma is defined as 
elevated IOP causing progressive optic nerve damage. In PEX-glaucoma, IOP 
elevation is caused by abnormal protein obstructing the trabecular meshwork.  
 
 Image and Data Acquisition 
All RNFL circle scans were performed by one examiner using the Spectralis® SD-
OCT system (Heidelberg Engineering GmbH, Heidelberg, Germany, software version 
5.1.2.). A pupil diameter of at least 4 mm was required for scanning. Within one 
session, three measurementswere taken with eye tracker and retest function 
engaged (Method A) and three measurements were taken without eye tracker and 
without retest function with manual positioning and repositioning of the scanning 
circle (Method B). Measurements performed with Method A were alternated by 
measurements performed with Method B to avoid systematic bias. 
 
SD-OCT RNFL thickness measurements were performed by using circlular scans 
with a scanning angle of 12° which equates a retinal diameter of 3.5 mm when 
assuming a standard corneal curvature of 7.7mm.Using a super luminescent diode 
with a center wavelength of 840 mm, the Spectralis® SD-OCT obtains up to 40,000 
A-scans/sec with a depth resolution of 7µm in tissue and a transversal optical 
resolution of 14µm in an average human eye. The transversal digital resolution 
depends on the tightness of calculated A-scans (pixels) and can be adjusted. In high 
resolutionmode (HR-mode) the device provides a transversal digital resolution of 
5µm. High speed mode (HS-mode) doubles the distance between A-scans. As a 
result, transversal digital resolution decreases to 11µm. A full RNFL circle scan 
contains 1536 A-scans in HR-mode and 768 A-scans in HS-mode along a 
peripapillary circle of 360°. In the present study, all scans were performed in HS-
mode, as HS-mode is commonly used for RNFL examinations in the utilized clinic. 
 
With dual-beam, a corresponding scanning laser ophthalmoscope (SLO) fundus 
image can be captured at the same time as the OCT measurement, enabling the 
 system to link every OCT scan (Fig 1A) to its corresponding position on the SLO 
fundus image (Fig 1B). Processing of SLO data and identification of specific patterns 
in retinal structures such as blood vessels allows scans to be marked as a reference 
and baseline. In follow-up examinations, the system recognizes the former scanning 
area on the retina and automatically positions the retest scan on the same location. 
During the measurement, online eye tracking provides a real-time adjustment of the 
OCT scanner on the simultaneously gathered SLO image in order to decrease 
motion artifacts, while the high scanning speed reduces the time for distracting eye 
movements to occur. To increase image quality, the Spectralis® SD-OCT includes an 
ART function (automatic real time). With ART activated, multiple frames (B-scans) 
are gathered during the scanning process and images are averaged for noise 
reduction.21, 22The number of frames can be adjusted. In this study, the ART function 
was set to 16 frames per B-scan for all measurements carried out. 
 
The first A-scan is processed temporally (0°), after which the scanner moves through 
superiorly (90°), nasally (180°), inferiorly (270°) and back to temporally to complete a 
full circle. During the measurement, a quality bar visualizes the signal to noise ratio. 
The quality scores range from 0 (poor quality) to 40 (excellent quality). For this study, 
scans with a quality of less than 25 were excluded and repeated until good quality 
was achieved. Likewise, scans with blinks during the scanning process were 
excluded and repeated.  
 
For the first RNFL measurement, the OCT scanning circle was manually positioned 
at the center of the optic disc while eye tracking was activated. The first acquired 
RNFL scan was set as a baseline for further retest scans (Method A). Every retest 
was performed alternately with a “traditional” scan with manual repositioning of the 
 scanning circle on the optic disc (Method B). Between each measurement, the 
subject was instructed to lean back before being repositioned on the headrest and 
the correction for spherical errors was readjusted.  
 
The Spectralis® SD-OCT system provides an algorithm to determine the inner and 
outer boundaryof the RNFL (Fig 1A). OCT data was analyzed by this algorithm to 
detect RNFL thickness along the circular scan in micrometers. The median thickness 
was plotted in a pie chart diagram representing the six sectors of the optic disc (Fig 
1D). For interpretation of the RNFL scan the optic disc is segmented as follows: 
temporal (T, 315° to 45°), superior temporal (TS, 45° to 90°), superior nasal (NS, 90° 
to 135°), nasal (N, 135° to 225°), inferior nasal (NI, 225° to 270°), inferior temporal 
(TI, 270° to 315°), together with an averaged global classification (G) and the 
papillomacular bundle (PMB, 338° to 8°). The calculated thickness profile (Fig 1C) 
refers to a set of normative RNFL thickness data collected from measurements in 
170 healthy subjects.23 Green areas represent the 95% normal range found in 
healthy subjects of the same age whereas values outside the 99% confidence 
interval of the normal distribution (0.01 < p < 0.05) are indicated in red. Yellow areas 
represent values outside the 95% confidence interval but within the 99% confidence 
interval of the normal distribution. 
 
Statistical Analyses 
For statistical analyses, the RNFL thickness of all sectors, the papillomacular bundle 
(PMB) and the global mean RNFL thickness (G) were analyzed. Analyses were 
conducted using PAWS/SPSS Statistics version 18 (IBM Corporation, New York, 
USA) and MedCalc version 11.2 (MedCalc Software, Mariakerke, Belgium). 
 
 A pilot study was conducted (5 eyes of 5 healthy controls and 5 eyes of 5 patients 
with a glaucoma diagnosis) to calculate the sample size that would be needed to 
distinguish a relevant difference in COV of ±1% between Method A and Method B. 
Sample size calculation was based on the measurements of measurement area 
G(global meanRNFL-thickness) in glaucomatous eyes according to the same 
examination protocol as described in the main study. The pilot study showed that 
when the sample size in the glaucoma group is 28, a single group t-test with a 0.05 
two sided significance level will have 95% power to detect the difference between a 
null hypothesis mean of 2.000and an alternative mean of 1.000, assuming that the 
standard deviation is 1.400. 
 
Descriptive statistics for quantitative variables such as means and standard 
deviations as well as relative frequencies for qualitative variables such as sex were 
conducted. A Student’s t-test was calculated for differences in age between healthy 
and glaucomatous eyes. 
 
One set of three RNFL thickness values obtained from three measurements using 
the same measurement method (Method A or Method B) in the same eye was used 
to calculate an intraclass correlation coefficient (ICC) and the coefficient of variation 
(COV). COV was defined as standard deviation divided by the arithmetic mean and 
was expressed in percentage. For both the glaucoma group and the control group 
this resulted in a population of COV values for measurements acquired by Method A 
and another population of COV values for measurements acquired by Method B. 
Thus the population statistics for COV were calculated. Such calculations were done 
separately in all measurement areas (G, TS, T, TI, NI, N, NS and PMB). 
 Consequently, differences in the mean COV between the two measurement methods 
(Method A minus Method B) were computed.  
 
Moreover, differences between the mean RNFL thickness in µm provided by Method 
A and Method B were computed for all measurement areas in both glaucoma group 
and healthy controls. 
 
A one sample Student’s t-test was applied to the differences of means to determine if 
Method A provides different measurement than Method B. Moreover, agreement of 
Method A and Method B was investigated with a Bland & Altman plot along with the 
corresponding 95% limits of agreement.24 A one sample Student’s t-test was also 
applied to COV differences in order to determine if Method A was more 
reproduciblethan Method B for healthy subjects and glaucoma patients 
(corresponding to a paired t-test). A two sample t-test was used to explore possible 
differences in COV reduction (Method A, Method B) between the healthy controls 
and the glaucoma group. A two sample t-test was used to determine if significant 
differences existed in thickness (Method A versus Method B) between healthy and 
glaucomatous eyes. 
 
A linear regression analysis for reproducibility(COVs) and global mean thickness (G) 
with age and sex as predictors was conducted in order to find associations between 
predictors and COVs for every sector, the PMB and for global mean RNFL thickness 
(G) for Method A separately for healthy and glaucomatous eyes. 
 
 A one-way ANOVA with aScheffè post-hoc test was conducted to investigate 
potential differences in the reproducibilityof sectors for both eye tracker and 
traditional measurement. 
 
Results of the statistical analyses with p-values under 0.05 were interpreted as 
statistically significant. 
 
RESULTS 
Demographic parameters 
One hundred and seven subjects were examined. Four patients had to be excluded, 
three due to poor fixation and one due to poor measurement quality and failure of 
RNFL thickness algorithm. Forty-two left and 61 right eyes were included. Table 1 
displays the characteristics and demographics of the study population. 
 
A Student’s t-test showed a significant difference in age between glaucoma patients 
and healthy controls (p = 0.007); whereas there was no significant difference in age 
between men and women (p = 0.813) in either group. 
 
Reliability of measurements performed with eyetracker and retest function 
The mean RNFL thickness is shown in Table 2 for each sector, the PMB and global 
mean thickness (G). As Table 2 shows, RNFL thickness measured higher in superior 
and inferior sectors compared to temporal and nasal sectors in both groups, 
regardless of the measurement method. Within both the glaucoma and the control 
groups, RNFL thickness values were very similar using each method (Table 2). 
RNFL thickness values in the glaucoma group were significantly decreased in all 
quadrants compared to healthy controls (mean RNFL decrease of 24µm, p < 0.001). 
  
Figure 2 shows a Bland & Altman plot for differences in mean RNFL thickness in 
µmfor both methods alongwith the corresponding 95% limits of agreement. Neither 
method was significantly biased towards thicker or thinner RNFL thickness values. 
 
Reproducibility of RNFL measurements 
Table 3 shows the COVs calculated from the three measurements. In healthy 
subjects, COVs for RNFL thickness measurement of the six sectors of the optic disc 
(T, TS, TI, N, NS, NI) measured withMethod B (without eye tracker and without retest 
function, with manual positioning of the scanning circle) ranged from 3.5% (temporal 
inferior sector, SD ± 0.023) to 7.4% (nasal, SD ± 0.051). COVs from measurements 
with Method A (with eye tracker and retest function engaged) ranged from 1.0% 
(temporal superior, SD ± 0.012) to 2.5% (nasal, SD ± 0.017). In glaucoma patients, 
COVs for measurements with Method B ranged from 5.8% (temporal, SD ± 0.034) to 
10.5% (nasal superior, SD ± 0.110); whereas COVs for measurements with Method 
A ranged from 1.6% (temporal, SD± 0.015) to 3.8% (temporal inferior, SD ± 0.040). 
For measurements in both groups with both methods, the COVs calculated for the 
global mean RNFL thickness(G) were even lower than in separate calculations for 
the sectors (1.6%, respectively 1.0% in healthy subjects; 2.7%, respectively 1.3% in 
glaucoma patients). 
 
Effect of eye tracker and retest function on reproducibility and RNFL thickness 
measured 
Differences in mean RNFL thickness and COVs between the two measurement 
methods are presented in Table 4. Significant differences in mean RNFL thickness 
between the two measurement methods were found in the control group for global 
 mean RNFL thickness (G, Method A +0.565 µm, p = 0.043) and sectors TS (-2.042 
µm, p = 0.018), NI (+3.464 µm, p = 0.002) and N (+2.304 µm, p = 0.009). There was 
no significant difference in mean RNFL thickness between the two measurement 
methods withinthe glaucoma group. Differences of COVs for the two measurement 
methods (Method A minus Method B) were all negative, providing strong evidence 
that Method A  is more reproduciblethan Method B Figure 3 displays the reduction of 
COVs by the Method A in a bar plot, together with its corresponding 95% CI.  
 
Linear regression analysis did not unveil any significant effect of sex nor age on 
reproducibility(COV) of measurements with Method A or Method B.  
 
For Method A, ANOVAs revealed that there are no differences in COV between 
sectors. For Method B there are differences (p = 0.001) in COVbetween sectors for 
both healthy subjects and glaucomatous patients. The TI sector (temporal inferior) is 
the highest reproducible sector measured. 
 
DISCUSSION 
Since its introduction in 1991, OCT technology has experienced a dramatic evolution 
and has quickly becomea popular resource in ophthalmologic imaging and 
diagnostics. In spite of its popularity and OCT’s role in glaucoma research, its role in 
diagnostics is still developing. The correlation between glaucoma progression and 
RNFL thinning is well-documented.8, 11 Evidence that the thinning of RNFL precedes 
loss of visual field function indicated that OCT could help detectthe onset of 
glaucomatous changes more sensitively than by testing the visual field.12 An earlier 
diagnosis of glaucomatous changes gives clinicians more time to establish an 
effective therapy and may help maintain patients’visual field function. 
  
Previous studies have kept record of the increasing reproducibility of RNFL thickness 
measurements performed with first-25, 26, second-27, 28 and third-generation29 TD-OCT 
technology as well as for the different SD-OCT devices30-35 that are currently 
available. The aim of this study was to investigate the contribution of twospecific 
software applications to achieve more reliable and higher reproducible RNFL 
thickness measurements. The improvements of SD-OCT have been well 
documented in the literature.30-35 While other studies have already been published on 
the reproducibility of RNFL thickness measurements with SD-OCT, the uniqueness 
of the present study lies in the differentiation between the two measurement 
modalities (Method A and Method B). Higher resolutions and faster scanning speeds 
of SD-OCT have made measurements more reproducible. The present study 
demonstrates that reproducibility can be further improved by the use of specific 
software for retest recognition and compensation for involuntary eye movement (eye 
tracker). 
 
The Spectralis® Software algorithm automatically detects RNFL. In some cases the 
software hasproblems detecting the corrected boundaryof the RNFL. In these cases, 
it is possible to manually correct the boundaryin the Spectalis® software. To avoid 
bias by a glaucoma specialist using manual correction of the RNFL boundary, we did 
not do this in the presented study. If it wasobvious that the automatic 
detectionfailed,thosestudy eyes wereexcluded. 
 
Our results show good reliability for measurements usingeye tracker and retest 
function (Method A). The Bland and Altman plot with 95% limits of agreement (Figure 
2) shows that RNFL-thickness values for the global measurement area (G) are 
 comparable between the two methods (Method A and Method B). The only significant 
difference in RNFL thickness was found in control patients where Method A resulted 
in higher values for the inferior nasal sector (NI), nasal sector (N) and mean global 
RNFL thickness (G), and lower values in the temporal superior sector (TS). As the 
differences are as low as 0.2 to 3.0µm, we consider them to be clinically irrelevant. 
Measurements with the new eye tracker and retest functions(Method A) are reliable 
and comparable to the thickness values measured without eye tracker and without 
retest function(Method B). 
 
Results of this study show excellent reproducibility and significant improvement of 
reproducibility of RNFL measurements by using the eye tracker and retest software. 
Using eye tracker and retest software (Method A) of Spectralis® SD-OCT, enhances 
reproducibility significantly (COV 2.7% to 1.3% for global mean RNFLthickness (G) in 
glaucomatous eyes, p=0.000). In glaucoma patients, the improvement of 
reproducibility was significantly higher than in controls. To our knowledge the present 
study is the first to report on the reproducibility of RNFL measurements using the 
Spectralis® SD-OCT device. 
 
Budenzet al.29 studied reproducibility of RFNL measurements with TD-OCT Stratus 
OCT3 (Carl Zeiss Meditec, Dublin, California) in 88 normal and 59 glaucomatous 
eyes and found COVs ranging from 3.7% (global mean RNFL thickness G) to 11.9% 
(nasal quadrant N) in glaucomatous eyes and from 1.7% (global mean RNFL 
thickness G) to 8.25% in normal eyes, respectively. Similar to the present study, the 
nasal quadrant was the least reproducible, whereas the temporal quadrant was the 
most reproducible. Also in that study, glaucomatous eyes showed less reproducibility 
than normal eyes, which was also reported by Blumentalet al.27 Though 
 reproducibility found in the present study is still higherin normal eyes than in 
glaucomatous eyes, our results show that eye tracker and retest software (Method A) 
had a higher impact on reproducibility in glaucomatous eyes than in normal eyes. 
This indicatesthat such software may help to reduce the gap in reproducibility 
previously found between measurements of glaucomatous and normal eyes. 
Mwanza and collegues35 studied intravisit and intervisit reproducibility of RNFL 
thickness and optic nerve head parameters measured with the SD-OCT Cirrus HD-
OCT (Carl Zeiss Meditec, Inc., Dublin, California) in 55 glaucomatous eyes. Similar to 
the present study, the mean RNFL thickness showed best intravisit reproducibility 
with a COV of 1.9%. Menkeet al. reported on the reproducibility of the 3D Fourier-
Domain OCT (3D OCT1000; Topcon, Tokyo, Japan) in 38 normal subjects 
performing 3 RNFL thickness measurements by two different operators.34 The mean 
COV was 4.1%. Highest reproducibility was found for the inner ring area (ETDRS-
scheme) with a COV of 1.9%, which compares with results of the present study for 
measurement Method B (without eye tracker and without retest function) in normal 
eyes (1.6%). Lee et al. used the test-retest function of Spectral OCT/SLO 
(Ophthalmic Technologies Inc, Toronto, Canada) to investigate reproducibility of 
RNFL thickness measurements in 98 normal and 79 glaucomatous eyes performing 
three measurements within one session.32 RNFL measurements showed good 
reproducibility for that device. As in the present study, best reproducibility was found 
for the global mean RNFL thickness, with a COV of 1.9% in normal and 2.0% in 
glaucomatous eyes. As all scans were performed with one method (retest) only, no 
conclusion regarding the specific effect of the retest function to enhance 
reproducibility could be drawn. 
 
 Reproducibilities found in different studies are not directly comparable, as different 
eyes and different study protocols are used. The results of the present study showed 
excellent reproducibility for measurements using the eye tracker and retest protocol 
(Method A) of Spectralis® SD-OCT. With lowest COVs of 1.0% in normal eyes and 
1.3% in glaucomatous eyes, the results show one of the best reproducibilities ever 
reported for RNFL thickness measurements in any OCT device available today.HS-
mode used in the present study only utilizes half the transversal resolution the device 
is capable of. If one were to use the full resolution of HR-mode, even higher 
reproducibility might be achieved. While other currently available OCT devices 
provide a scanning resolution comparable to the device used in the present study 
and also include test-retest software, the Spectralis® SD-OCT is the first device to 
integrate real-time eye tracking. The significant improvement of reproducibility 
attained by using this software in the present study indicates that improvement in 
reproducibility cannot entirely be accounted for by higher resolutions and faster 
scanning speeds of the latest SD-OCT devices, but also has to be understood as a 
result of more sophisticated software applications. These findings may have 
implications for the design and development of the next generation of OCT devices. 
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 Table 1. Demographic characteristics of glaucoma patients and healthy subjects 
 Control Glaucoma Total subjects 
Eyes (n) 56 (54.37%) 47 (45.63%) 103 
Mean age (y)* 46,31 ± 19,56 68,96 ± 16,22 56,65 ± 21.30 
Female (n) 28 (50%) 23 (49%) 51 (49.5%) 
 
*± Standard derivation (SD) 
 Table 2. Mean RNFL-thickness in micrometers as the mean ± SD for both 
examination methods in glaucoma patients and controls 
  Controls  Glaucoma 
  Method B* Method A†  Method B* Method A† 
G‡ 95 ± 11.6 96 ± 12.6  71 ± 16.5 71 ± 16.9 
TS 130 ± 17.8 128 ± 18.2  96 ± 29.4 96 ± 28.7 
T 71 ± 10.8 70 ± 11.2  61 ± 14.6 60 ± 183.9 
TI 138 ± 19.2 138 ± 20.2  91 ± 36.7 90 ± 37.1 
NI 103 ± 23.7 106 ± 26.2  75 ± 20.1 77 ± 23.0 
N 71 ± 15.8 73 ± 18.2  56 ± 17.0 57 ± 18.9 
NS 108 ± 25.8 108 ± 28.4  70 ± 26.4 72 ± 28.3 
PMB 55 ± 9.9 54 ± 11.3  51 ± 11.2 50 ± 11.7 
 
 
*Method B = Measurements without eye tracker and without retest software, with 
manual positioning of the scanning circle 
†Method A = Measurements with eye tracker and retest software engaged 
 
‡G = 0-360°, T = 315°-45°, TS = 45°-90°, NS = 90°-135°, N = 135°-225°, NI = 225°-
270°, TI = 270°-315°, PMB = 338°-8° 
 
 Table 3.Intraclass Correlation Coefficient (ICC) and Coefficient of variation (COV) for measurements using eye tracker and retest 
software and measurements without eye tracker and without retest software in glaucoma patients and controls 
  Controls  Glaucoma 
 Method B*  Method A†  Method B*  Method A† 
 ICC§ COV  ICC§ COV  ICC§ COV  ICC§ COV 
G‡ 0.98 (0.96) 1.6%  0.99 (0.98) 1.0%  0.98 (0.96) 2.7%  0.99 (0.98) 1.3% 
TS 0.86 (0.79) 4.4%  0.99 (0.79) 1.4%  0.92 (0.88) 6.5%  0.99 (00.99) 1.8% 
T 0.83 (0.75) 5.6%  0.99 (0.97) 1.5%  0.92 (0.87) 5.8%  0.99 (0.98) 1.6% 
TI 0.91 (0.87) 3.5%  0.97 (0.95) 1.4%  0.97 (0.97) 5.9%  0.98 (0.96) 3.5% 
NI 0.91 (0.86) 6.3%  0.98 (0.97) 2.1%  0.88 (0.87) 8.7%  0.99 (0.98) 2.3% 
N 0.83 (0.75) 7.4%  0.99 (0.97) 2.5%  0.89 (0.83) 9.5%  0.99 (0.98) 3.0% 
NS 0.91 (0.86) 6.0%  0.99 (0.98) 2.1%  0.89 (0.83) 10.5%  0.99 (0.98) 3.8% 
PMB 0.85 (0.77) 6.5%  0.93 (0.89) 3.0%  0.84 (0.75) 7.9%  0.97 (0.95) 2.8% 
 
*Method B = Measurements without eye tracker and without retest software, with manual positioning of the scanning circle 
†Method A = Measurements with eye tracker and retest software engaged 
 
‡G = 0-360°, T = 315°-45°, TS = 45°-90°, NS = 90°-135°, N = 135°-225°, NI = 225°-270°, TI = 270°-315°, PMB = 338°-8° 
§ICC, with lower 95% confidence intervalin parentheses;  
 
 Table 4. Differences in COV (Method A† – Method B*) and mean RNFL thickness for glaucoma patients and healthy controls 
  Healthy controls  Glaucoma patients 
  One sample Student’s t-test on differences  One sample Student’s t-test on differences 
  95% CI  95% CI 
  
p-value Mean difference lower upper  
p-value Mean difference lower upper 
G‡ < 0.001 -0.005 -0.007 -0.003  < 0.001 -0.015 -0.021 -0.008 
TS < 0.001 -0.030 -0.038 -0.023  < 0.001 -0.047 -0.064 -0.030 
T < 0.001 -0.041 -0.05 -0.033  < 0.001 -0.042 -0.052 -0.032 
TI < 0.001 -0.021 -0.029 -0.013  0.210 -0.024 -0.061 0.014 
NI < 0.001 -0.042 -0.052 -0.032  < 0.001 -0.064 -0.082 -0.046 
N < 0.001 -0.049 -0.063 -0.035  < 0.001 -0.065 -0.084 -0.046 
NS < 0.001 -0.040 -0.049 -0.031  < 0.001 -0.068 -0.100 -0.034 
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PMB < 0.001 -0.036 -0.049 -0.022  < 0.001 -0.051 -0.066 -0.037 
           
G 0.043 0.565 0.017 1.114  0.357 0.443 -0.515 1.403 
TS 0.018 -2.042 -3.726 -0.358  0.941 0.082 -2.138 2.302 
T 0.218 -0.667 -1.739 0.407  0.196 -1.078 -2.731 0.576 
TI 0.601 0.417 -1.171 2.005  0.267 -1.163 -3.246 0.921 
NI 0.002 3.464 1.367 5.562  0.136 2.082 -0.680 4.844 
N 0.009 2.304 0.607 4.000  0.237 1.177 -0.800 3.155 
S 0.635 -0.500 -2.597 1.594  0.112 1.869 -0.454 4.193 
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PMB 0.517 -0.315 -1.284 0.654  0.292 -1.138 -3.286 1.011 
 
*Method B = Measurements without eye tracker and without retest software, with manual positioning of the scanning circle 
† Method A = Measurements with eye tracker and retest software engaged 
 ‡G = 0-360°, T = 315°-45°, TS = 45°-90°, NS = 90°-135°, N = 135°-225°, NI = 225°-270°, TI = 270°-315°, PMB = 338°-8° 
  
Figure 1. Circular peripapillary optical coherence tomogram of a normal right eye 
(1A) with its corresponding fundus image (1B) obtained with the dual beam scanning 
laser ophthalmoscope. Red lines in the OCT B-Scan (1A) indicate the inner and outer 
border of the retinal nerve fiber layer (RNFL) found by the algorithm. In 1C, the 
measured RNFL thickness is plotted on the thickness values measured in healthy 
subjects of the same age. The mean RNFL thickness of sectors, the 
peripapillaryboundle and the global mean RNFL thickness is shown in 1D. 
  
 
Figure 2. Bland and Altman plot for differences in mean global RNFL thickness 
measured with Method A† (meanGA) minus Method B* (meanGB) in normal and 
glaucomatous eyes. 
 
*Method B = Measurements without eye tracker and without retest software, with 
manual positioning of the scanning circle 
† Method A = Measurements with eye tracker and retest software engaged
  
 
Figure 3.ΔCOVG = Difference of coefficients of variation found for both methods 
(Method A† minus Method B*) in measurements of the global mean RNFLthickness 
(G).The reduction of COV (gain of Reproducibility) is shown as a bar, together with 
the corresponding 95% confidence interval. 
 
*Method B = Measurements without eye tracker and without retest software, with 
manual positioning of the scanning circle 
† Method A = Measurements with eye tracker and retest software engaged 
 
  
 
